Search research articles
Contact Us
Filters
Showing results (21-30 of 115) with videos related to
Page
of 12
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 15, 2015
Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis
Hartmut Grasemann, Tanja Gonska, Julie Avolio, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 24, 2002
Activation of ion secretion via proteinase-activated receptor-2 in human colon
Marcus Mall, Tanja Gonska, Jörg Thomas, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 4, 2018
Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His
Katherine Keenan, Annie Dupuis, Katherine Griffin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 11, 2014
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?
Katherine Keenan, Julie Avolio, Claudia Rueckes-Nilges, et al.
Pediatric Research
|
September 1, 2018
Hydrogen peroxide promotes gastric motility in the newborn rat
Andre Felipe Fajardo, Curtis Sobchak, Yulia Shifrin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 22, 2022
Aquagenic wrinkling of the palms in cystic fibrosis patients treated with ivacaftor
Eyal Jacobi, Melinda Solomon, Julie Avolio, et al.
The European Respiratory Journal
|
October 12, 2019
Long-term effect of CFTR modulator therapy on airway nitric oxide
Hartmut Grasemann, Michelle Klingel, Julie Avolio, et al.
Thorax
|
March 6, 2016
Lung clearance index response in patients with CF with class III CFTR mutations
Mica Kane, Tanja Gonska, Renee Jensen, et al.
Frontiers in Pharmacology
|
July 31, 2023
Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
Marialena Mouzaki, Annie Dupuis, Julie Avolio, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 4, 2021
CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis
Michelle J Gould, Haley Smith, Jonathan H Rayment, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 115) with videos related to
Sort By:
Page
of 12
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 15, 2015
Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis
Hartmut Grasemann, Tanja Gonska, Julie Avolio, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 24, 2002
Activation of ion secretion via proteinase-activated receptor-2 in human colon
Marcus Mall, Tanja Gonska, Jörg Thomas, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 4, 2018
Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His
Katherine Keenan, Annie Dupuis, Katherine Griffin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 11, 2014
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?
Katherine Keenan, Julie Avolio, Claudia Rueckes-Nilges, et al.
Pediatric Research
|
September 1, 2018
Hydrogen peroxide promotes gastric motility in the newborn rat
Andre Felipe Fajardo, Curtis Sobchak, Yulia Shifrin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 22, 2022
Aquagenic wrinkling of the palms in cystic fibrosis patients treated with ivacaftor
Eyal Jacobi, Melinda Solomon, Julie Avolio, et al.
The European Respiratory Journal
|
October 12, 2019
Long-term effect of CFTR modulator therapy on airway nitric oxide
Hartmut Grasemann, Michelle Klingel, Julie Avolio, et al.
Thorax
|
March 6, 2016
Lung clearance index response in patients with CF with class III CFTR mutations
Mica Kane, Tanja Gonska, Renee Jensen, et al.
Frontiers in Pharmacology
|
July 31, 2023
Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
Marialena Mouzaki, Annie Dupuis, Julie Avolio, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 4, 2021
CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis
Michelle J Gould, Haley Smith, Jonathan H Rayment, et al.
Page
of 12